Hypoxic-ischemic encephalopathy (HIE), also known as perinatal asphyxia, neonatal encephalopathy, and birth asphyxia, refers to a type of newborn brain damage caused by limited blood flow and oxygen deprivation. This is defined as a form of brain injury which is basically a broad term used for any harm that a baby experiences at or near the time of birth. The increase in the number of people suffering from neonatal hypoxic-ischemic encephalopathy across the globe acts as one of the major factors driving the growth of the global neonatal hypoxic-ischemic encephalopathy market.

Data Bridge Market Research analyses that the global neonatal hypoxic-ischemic encephalopathy market which was USD 1,040.13 million in 2022, is expected to reach USD 1,911.00 million by 2030, and is expected to undergo a CAGR of 7.9% during the forecast period 2023-2030. “Breathing problems” dominate the symptoms segment of the global neonatal hypoxic-ischemic encephalopathy market owing to growing cases of respiratory problems in neonates. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Get the sample copy of Report @- https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-neonatal-hypoxic-ischemic-encephalopathy-market

The global neonatal hypoxic-ischemic encephalopathy market is segmented on the basis of symptoms, treatment, mode of administration, distribution channel, end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Symptoms

  • Breathing Problems
  • Feeding Problems
  • Missing Reflexes
  • Seizures
  • Low Apgar Scores
  • Low or High Muscle Tone
  • Altered Level of Consciousness

Treatment

  • Therapeutic hypothermia
  • Drugs
  • Other

 Mode of Administration

  • Injectable
  • Oral
  • Others

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

End-User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Highlight of Table of Content:

·        Chapter 1: Market overview

·        Chapter 2: Global Neonatal Hypoxic-Ischemic Encephalopathy Market analysis

·        Chapter 3: Regional analysis of the Global Neonatal Hypoxic-Ischemic Encephalopathy Market

·        Chapter 4: Market segmentation based on types and applications

·        Chapter 5: Revenue analysis based on types and applications

·        Chapter 6: Market share

·        Chapter 7: Competitive Landscape

·        Chapter 8: Drivers, Restraints, Challenges, and Opportunities

·        Chapter 9: Gross Margin and Price Analysis

Get Details TOC of this report@- https://www.databridgemarketresearch.com/toc/?dbmr=global-neonatal-hypoxic-ischemic-encephalopathy-market

Some of the major players operating in the global neonatal hypoxic-ischemic encephalopathy market are:

  • Eisai Co. Ltd. (Japan)
  • Pfizer, Inc. (U.S.)
  • Sanofi (France)
  • Teva Pharmaceuticals Industries Ltd. (Israel)
  • Novartis AG (Switzerland)
  • Allergan (Ireland)
  • Merz Pharma (Germany)
  • Johnson & Johnson Services, Inc. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Bristol-Myers Squibb Company (U.S.)
  • AbbVie Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Bayer AG (Germany)
  • Biogen (U.S.)
  • AstraZeneca (U.K.)
  • VTV Therapeutics (U.S.)
  • H. Lundbeck A/S (Denmark)
  • TauRx Pharmaceuticals Ltd (U.K.)
  • DAIICHI SANKYO COMPANY, LIMITED (Japan)

Profound Questions Answered in this Report:

·        What is the growth rate of various stages in the value chain of the industry?

·        Which region has the highest growth rate and size of the emerging market by value in 2022 Neonatal Hypoxic-Ischemic Encephalopathy Market?

·        Who are the competitive players in Global?

·        Which region has the largest share and degree of competition in the industry?

·        What is the CAGR of the market during the forecast period 2022 to 2029?

·        Which region is expected to hold the highest market share for the market?

·        What is the main driver of the Global Neonatal Hypoxic-Ischemic Encephalopathy Market?

·        What is sales volume, revenue, and price analysis of top players of the market?

·        What are the market opportunities and threats faced by the vendors in the industry?

·        What has been the impact of COVID-19 on the Global Neonatal Hypoxic-Ischemic Encephalopathy Market?

 

Asceses Full report@ https://www.databridgemarketresearch.com/reports/global-neonatal-hypoxic-ischemic-encephalopathy-market

Browser Related Report@-

Dental Biomaterials Market

Medical Laboratories Market

Gel Stent Market

Gigantism Drugs Market

Extracorporeal Membrane Oxygenation Market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com